Enovis Jumps 12% as Q3 Profit Swing and Guidance Raise Beat Estimates
ENOV sits 66% above its 52-week low of $16.7.
Summary
Enovis swung to a $3.1 million third-quarter profit, or 6 cents a share, from a $571.1 million loss a year earlier that carried a large goodwill impairment charge. Adjusted EPS of 88 cents beat the FactSet consensus of 77 cents, and net sales of $558.7 million edged past the $557.1 million analysts expected. Shares rose 12% to $27.44 by midday, extending a roughly 3% year-to-date gain. Management narrowed full-year revenue to $2.32-$2.35 billion and lifted adjusted EPS guidance to $3.58-$3.79 from $3.52-$3.73. The beat-and-raise follows the September binding offer for eCential Robotics and recent open-market buying by the CEO and CAO near $19-$20 a share.
At the time of this announcement, ENOV was trading at $27.64 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $16.70 to $32.41. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.